Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer Outcomes.
Sign Up to like & getrecommendations! Published in 2018 at "European urology oncology"
DOI: 10.1016/j.euo.2018.04.005
Abstract: Background Owing to surgical complexity and controversy regarding indications, there are wide practice variations in the use of postchemotherapy retroperitoneal lymph node dissection (PC-RPLND). Objective To evaluate patterns of PC-RPLND use in the USA and… read more here.
Keywords: node dissection; rplnd; postchemotherapy retroperitoneal; insurance ... See more keywords
Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer.
Sign Up to like & getrecommendations! Published in 2019 at "European urology oncology"
DOI: 10.1016/j.euo.2019.01.014
Abstract: BACKGROUND Postchemotherapy retroperitoneal lymph node dissection (pcRPLND) is mandated in patients with nonseminomatous germ cell tumor found to have residual masses after chemotherapy. Performed via the open approach, pcRPLND can incur significant perioperative morbidity. OBJECTIVE… read more here.
Keywords: pcrplnd; postchemotherapy retroperitoneal; cancer; pcrplnd pcrplnd ... See more keywords
Postchemotherapy retroperitoneal residual mass resection for germ cell testicular tumors: a single-center experience.
Sign Up to like & getrecommendations! Published in 2022 at "Revista da Associacao Medica Brasileira"
DOI: 10.1590/1806-9282.20211247
Abstract: OBJECTIVE Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) plays an important role in the management of advanced germ cell testicular tumors. Bilateral template lymph node dissection is considered a standard treatment in postchemotherapy residual masses; however,… read more here.
Keywords: germ cell; postchemotherapy retroperitoneal; postchemotherapy; center ... See more keywords